- CA$940.30m
- CA$1.03bn
- $99.38m
- 35
- 41
- 83
- 53
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 2.53 | ||
| Price to Tang. Book | 6.2 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 5.54 | ||
| EV to EBITDA | 154.4 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 0.71% | ||
| Return on Equity | -34.2% | ||
| Operating Margin | 2.42% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 49.21 | 54.45 | 74.63 | 88.13 | 99.38 | 103.12 | n/a | 27.11% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Vireo Growth Inc. is a vertically integrated cannabis company. The Company's operations include cultivation, manufacturing, wholesale and retail business lines. The Company cultivates, manufactures, and distributes cannabis products to third parties in wholesale markets and cultivates, manufactures, and sells cannabis products directly to approved patients and adult-use-customers in its owned or operated retail stores. It has developed proprietary cannabis strains, cultivation methods, carbon dioxide extraction, ethanol extraction, and other processes related to the production, refinement, and packaging of cannabis products. It grows cannabis in outdoor, indoor and greenhouse facilities. It converts cannabis biomass into formulated oil using a variety of extraction techniques. Some of this oil is used to produce consumer products such as vaporizer cartridges and edibles. Its brands include Vireo Spectrum, Proper, Boundary Waters, HiColor, Kings & Queens, 1937, and Dr. Westwater.
Directors
- Kyle Kingsley CHM (45)
- John Heller CFO (52)
- Christian Gonzalez COO (40)
- Patrick Peters EVP (47)
- Amber Shimpa CAD (42)
- J. Michael Schroeder CCO (53)
- Stephen Dahmer OTH (46)
- Josh Rosen DRC
- Chelsea Grayson IND (49)
- Ross Hussey IND (42)
- Victor Mancebo IND (37)
- Judd Nordquist IND (51)
- Last Annual
- December 31st, 2024
- Last Interim
- June 30th, 2025
- Incorporated
- December 9th, 2013
- Public Since
- May 9th, 2005
- No. of Employees
- 490
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
Canadian Securities Exchange- Shares in Issue
- 949,802,390
- Address
- 207 South 9th Street, MINNEAPOLIS, 55402
- Web
- https://goodnessgrowth.com/
- Phone
- +1 6046175421
- Auditors
- Davidson & Co LLP
Latest News for VREO
Upcoming Events for VREO
Q3 2025 Vireo Growth Inc Earnings Release
Q3 2025 Vireo Growth Inc Earnings Release
Similar to VREO
1933 Industries
Canadian Securities Exchange
1CM
Canadian Securities Exchange
Adastra Holdings
Canadian Securities Exchange
Aion Therapeutic
Canadian Securities Exchange
Asia Green Biotechnology
Canadian Securities Exchange
FAQ
As of Today at 23:59 UTC, shares in Vireo Growth are trading at CA$0.99. This share price information is delayed by 15 minutes.
Shares in Vireo Growth last closed at CA$0.99 and the price had moved by +57.14% over the past 365 days. In terms of relative price strength the Vireo Growth share price has outperformed the Toronto Stock Exchange 300 Composite Index by +29.15% over the past year.
The overall consensus recommendation for Vireo Growth is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreVireo Growth does not currently pay a dividend.
Vireo Growth does not currently pay a dividend.
Vireo Growth does not currently pay a dividend.
To buy shares in Vireo Growth you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of CA$0.99, shares in Vireo Growth had a market capitalisation of CA$940.30m.
Here are the trading details for Vireo Growth:
- Country of listing: Canada
- Exchange: CNX
- Ticker Symbol: VREO
Based on an overall assessment of its quality, value and momentum Vireo Growth is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Vireo Growth is CA$0.65. That is 34.08% below the last closing price of CA$0.99.
Analysts covering Vireo Growth currently have a consensus Earnings Per Share (EPS) forecast of -$0.09 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Vireo Growth. Over the past six months, its share price has outperformed the Toronto Stock Exchange 300 Composite Index by +39.5%.
As of the last closing price of CA$0.99, shares in Vireo Growth were trading +58.43% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Vireo Growth PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at CA$0.99.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Vireo Growth's management team is headed by:
- Kyle Kingsley - CHM
- John Heller - CFO
- Christian Gonzalez - COO
- Patrick Peters - EVP
- Amber Shimpa - CAD
- J. Michael Schroeder - CCO
- Stephen Dahmer - OTH
- Josh Rosen - DRC
- Chelsea Grayson - IND
- Ross Hussey - IND
- Victor Mancebo - IND
- Judd Nordquist - IND